Brief: NeuroSense Therapeutics FY EPS USD -0.44
31/03/2026 14:20
Mar 31 (Reuters) - NeuroSense Therapeutics FY operating income USD -11.085 million.
NRSN — Neurosense Therapeutics News Story
0.000.00%
Last trade - 00:00Last trade - 00:00Last trade - 00:00Mar 31 (Reuters) - NeuroSense Therapeutics FY operating income USD -11.085 million.